2017-2022 Global and Japan Dermatology Drug Market Analysis Report

August 2017 | 118 pages | ID: 2FE4473BBCDEN
JP Research

Abstracts

The global Dermatology Drug market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.

This report, with focus on top players in the global and Japan, studies the Dermatology Drug market's development status and future trend in the global and Japan. It splits Dermatology Drug market by type and by applications to fully and deeply research and reveal market profile and prospect.

The major players include

• AbbVie (U.S.)
• Johnson & Johnson (U.S.)
• Bayer (Germany)
• Galderma (Switzerland)
• Bristol-Myers Squibb (U.S.)
• Novartis (China)
• Pfizer (U.S.)
• Merz Pharma (Germany)
• Valeant (Canada)
• LEO Pharma (Denmark)
• GlaxoSmithKline (UK)

Geographically, this report splits the Global market into the following regions:

• Asia Pacific
• Japan
• Tokyo
• Yokohama
• Osaka
• Nagoya
• Others
• China
• Korea
• India
• Others
• Europe
• France
• Germany
• United Kingdom
• Italy
• Russia
• Others
• North America
• United States
• Canada
• Latin America
• Brazil
• Mexico
• Others
• Southeast Asia
• Singapore
• Malaysia
• Vietnam
• Myanmar
• Thailand
• Indonesia
• Philippines
• Others
• Middle East & Africa
• Saudi Arabia
• Iran
• UAE
• Turkey
• Israel
• Egypt
• South Africa
• Others

On the basis of product, the Dermatology Drug market is primarily split into
By Route of Administration

• External Use
• Oral
• Injection

By Form

• Ointment
• Liquid
• Powder
• Spray

Key Applications

• Psoriasis
• Skin Infections
• Acne
• Dermatitis
• Other

Contents

1 DERMATOLOGY DRUG OVERVIEW

1.1 Product Overview and Scope of Dermatology Drug
1.2 Global and Japan Dermatology Drug Market by Applications/End Users
  1.2.1 Japan Dermatology Drug Sales (K MT) and Market Share Comparison by Applications (2012-2017)
    1.2.1.1 Japan Dermatology Drug Sales (K MT) and Market Share by Applications (2012-2017)
    1.2.1.2 Japan Dermatology Drug Sales Growth Rate (%) by Applications (2012-2017)
    1.2.1.3 Market Drivers and Opportunities
  1.2.2 Japan Dermatology Drug Sales (K MT) and Market Share Comparison by Applications (2012-2017)
  1.2.3 Global Dermatology Drug Sales by Application (2012-2017)
    1.2.3.1 Global Dermatology Drug Sales (K MT) and Market Share by Applications (2012-2017)
    1.2.3.2 Global Dermatology Drug Sales Growth Rate (%) by Applications (2012-2017)
    1.2.3.3 Market Drivers and Opportunities
  1.2.4 Global Dermatology Drug Sales (K MT) and Market Share Comparison by Applications (2012-2017)
  1.2.5 Psoriasis
  1.2.6 Skin Infections
  1.2.7 Acne
  1.2.8 Dermatitis
  1.2.9 Other
1.3 Global and Japan Market Size (Sales and Revenue) of Dermatology Drug (2012-2017)
  1.3.1 Japan Market Size (Sales and Revenue) of Dermatology Drug (2012-2017)
    1.3.1.1 Japan Dermatology Drug Sales (K MT) and Growth Rate (%) (2012-2017)
    1.3.1.2 Japan Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2017)
  1.3.2 Global Market Size (Sales and Revenue) of Dermatology Drug (2012-2017)
    1.3.2.1 Global Dermatology Drug Sales (K MT) and Growth Rate (%) (2012-2017)
    1.3.2.2 Global Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2017)
1.4 Global and Japan Classification of Dermatology Drug by Route of Administration
  1.4.1 Japan Dermatology Drug Sales (K MT) and Market Share by Route of Administration (2012-2017)
  1.4.2 Global Dermatology Drug Sales (K MT) and Market Share by Route of Administration (2012-2017)
  1.4.3 Japan Dermatology Drug Revenue (Million USD) and Market Share by Route of Administration (2012-2017)
  1.4.4 Global Dermatology Drug Revenue (Million USD) and Market Share by Route of Administration (2012-2017)
  1.4.5 Japan Dermatology Drug Price (USD/MT) by Route of Administration (2012-2017)
  1.4.6 Global Dermatology Drug Price (USD/MT) by Route of Administration (2012-2017)
  1.4.7 Japan Dermatology Drug Sales Growth Rate (%) by Route of Administration (2012-2017)
  1.4.8 Global Dermatology Drug Sales Growth Rate (%) by Route of Administration (2012-2017)
  1.4.9 External Use
  1.4.10 Oral
  1.4.11 Injection
1.5 Global and Japan Classification of Dermatology Drug by Form
  1.5.1 Japan Dermatology Drug Sales (K MT) and Market Share by Form (2012-2017)
  1.5.2 Global Dermatology Drug Sales (K MT) and Market Share by Form (2012-2017)
  1.5.3 Japan Dermatology Drug Revenue (Million USD) and Market Share by Form (2012-2017)
  1.5.4 Global Dermatology Drug Revenue (Million USD) and Market Share by Form (2012-2017)
  1.5.5 Japan Dermatology Drug Price (USD/MT) by Form (2012-2017)
  1.5.6 Global Dermatology Drug Price (USD/MT) by Form (2012-2017)
  1.5.7 Japan Dermatology Drug Sales Growth Rate (%) by Form (2012-2017)
  1.5.8 Global Dermatology Drug Sales Growth Rate (%) by Form (2012-2017)
  1.5.9 Ointment
  1.5.10 Liquid
  1.5.11 Powder
  1.5.12 Spray

2 GLOBAL AND JAPAN DERMATOLOGY DRUG MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 Japan Dermatology Drug Market Competition by Players/Manufacturers
  2.1.1 Japan Dermatology Drug Sales and Market Share of Key Players/Manufacturers (2012-2017)
  2.1.2 Japan Dermatology Drug Revenue and Share by Players/Manufacturers (2012-2017)
  2.1.3 Japan Dermatology Drug Average Price (USD/MT) by Players/Manufacturers (2012-2017)
  2.1.4 Japan Dermatology Drug Market Competitive Situation and Trends
    2.1.4.1 Japan Dermatology Drug Market Concentration Rate
    2.1.4.2 Japan Dermatology Drug Market Share of Top 3 and Top 5 Players/Manufacturers
    2.1.4.3 Mergers & Acquisitions, Expansion in Japan Market
  2.1.5 Japan Players/Manufacturers Dermatology Drug Manufacturing Base Distribution, Sales Area, Product Types
2.2 Global Dermatology Drug Market Competition by Players/Manufacturers
  2.2.1 Global Dermatology Drug Sales and Market Share of Key Players/Manufacturers (2012-2017)
  2.2.2 Global Dermatology Drug Revenue and Share by Players/Manufacturers (2012-2017)
  2.2.3 Global Dermatology Drug Average Price (USD/MT) by Players/Manufacturers (2012-2017)
  2.2.4 Global Dermatology Drug Market Competitive Situation and Trends
    2.2.4.1 Global Dermatology Drug Market Concentration Rate
    2.2.4.2 Global Dermatology Drug Market Share of Top 3 and Top 5 Players/Manufacturers
    2.2.4.3 Mergers & Acquisitions, Expansion in Global Market
  2.2.5 Global Players/Manufacturers Dermatology Drug Manufacturing Base Distribution, Sales Area, Product Types

3 GLOBAL AND JAPAN DERMATOLOGY DRUG SALES AND REVENUE BY REGIONS (2012-2017)

3.1 Asia Pacific Dermatology Drug Sales and Revenue by Regions (2012-2017)
  3.1.1 Japan Dermatology Drug Sales and Revenue (2012-2017)
    3.1.1.1 Japan Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.1.1.2 Japan Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.1.1.3 Japan Dermatology Drug Price (USD/MT)(2012-2017)
  3.1.2 China Dermatology Drug Sales and Revenue (2012-2017)
    3.1.2.1 China Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.1.2.2 China Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.1.2.3 China Dermatology Drug Price (USD/MT)(2012-2017)
  3.1.3 Korea Dermatology Drug Sales and Revenue (2012-2017)
    3.1.3.1 Korea Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.1.3.2 Korea Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.1.3.3 Korea Dermatology Drug Price (USD/MT)(2012-2017)
  3.1.4 India Dermatology Drug Sales and Revenue (2012-2017)
    3.1.4.1 India Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.1.4.2 India Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.1.4.3 India Dermatology Drug Price (USD/MT)(2012-2017)
  3.1.5 Others Dermatology Drug Sales and Revenue (2012-2017)
    3.1.5.1 Others Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.1.5.2 Others Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.1.5.3 Others Dermatology Drug Price (USD/MT)(2012-2017)
3.2 Europe Dermatology Drug Sales and Revenue by Regions (2012-2017)
  3.2.1 France Dermatology Drug Sales and Revenue (2012-2017)
    3.2.1.1 France Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.2.1.2 France Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.2.1.3 France Dermatology Drug Price (USD/MT)(2012-2017)
  3.2.2 Germany Dermatology Drug Sales and Revenue (2012-2017)
    3.2.2.1 Germany Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.2.2.2 Germany Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.2.2.3 Germany Dermatology Drug Price (USD/MT)(2012-2017)
  3.2.3 United Kingdom Dermatology Drug Sales and Revenue (2012-2017)
    3.2.3.1 United Kingdom Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.2.3.2 United Kingdom Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.2.3.3 United Kingdom Dermatology Drug Price (USD/MT)(2012-2017)
  3.2.4 Italy Dermatology Drug Sales and Revenue (2012-2017)
    3.2.4.1 Italy Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.2.4.2 Italy Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.2.4.3 Italy Dermatology Drug Price (USD/MT)(2012-2017)
  3.2.5 Russia Dermatology Drug Sales and Revenue (2012-2017)
    3.2.5.1 Russia Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.2.5.2 Russia Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.2.5.3 Russia Dermatology Drug Price (USD/MT)(2012-2017)
  3.2.6 Others Dermatology Drug Sales and Revenue (2012-2017)
    3.2.6.1 Others Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.2.6.2 Others Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.2.6.3 Others Dermatology Drug Price (USD/MT)(2012-2017)
3.3 North America Dermatology Drug Sales and Revenue by Regions (2012-2017)
  3.3.1 United States Dermatology Drug Sales and Revenue (2012-2017)
    3.3.1.1 United States Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.3.1.2 United States Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.3.1.3 United States Dermatology Drug Price (USD/MT)(2012-2017)
  3.3.2 Canada Dermatology Drug Sales and Revenue (2012-2017)
    3.3.2.1 Canada Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.3.2.2 Canada Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.3.2.3 Canada Dermatology Drug Price (USD/MT)(2012-2017)
3.4 Latin America Dermatology Drug Sales and Revenue by Regions (2012-2017)
  3.4.1 Brazil Dermatology Drug Sales and Revenue (2012-2017)
    3.4.1.1 Brazil Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.4.1.2 Brazil Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.4.1.3 Brazil Dermatology Drug Price (USD/MT)(2012-2017)
  3.4.2 Mexico Dermatology Drug Sales and Revenue (2012-2017)
    3.4.2.1 Mexico Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.4.2.2 Mexico Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.4.2.3 Mexico Dermatology Drug Price (USD/MT)(2012-2017)
  3.4.3 Others Dermatology Drug Sales and Revenue (2012-2017)
    3.4.3.1 Others Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.4.3.2 Others Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.4.3.3 Others Dermatology Drug Price (USD/MT)(2012-2017)
3.5 Southeast Asia Dermatology Drug Sales and Revenue by Regions (2012-2017)
  3.5.1 Singapore Dermatology Drug Sales and Revenue (2012-2017)
    3.5.1.1 Singapore Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.5.1.2 Singapore Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.5.1.3 Singapore Dermatology Drug Price (USD/MT)(2012-2017)
  3.5.2 Malaysia Dermatology Drug Sales and Revenue (2012-2017)
    3.5.2.1 Malaysia Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.5.2.2 Malaysia Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.5.2.3 Malaysia Dermatology Drug Price (USD/MT)(2012-2017)
  3.5.3 Vietnam Dermatology Drug Sales and Revenue (2012-2017)
    3.5.3.1 Vietnam Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.5.3.2 Vietnam Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.5.3.3 Vietnam Dermatology Drug Price (USD/MT)(2012-2017)
  3.5.4 Myanmar Dermatology Drug Sales and Revenue (2012-2017)
    3.5.4.1 Myanmar Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.5.4.2 Myanmar Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.5.4.3 Myanmar Dermatology Drug Price (USD/MT)(2012-2017)
  3.5.5 Thailand Dermatology Drug Sales and Revenue (2012-2017)
    3.5.5.1 Thailand Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.5.5.2 Thailand Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.5.5.3 Thailand Dermatology Drug Price (USD/MT)(2012-2017)
  3.5.6 Indonesia Dermatology Drug Sales and Revenue (2012-2017)
    3.5.6.1 Indonesia Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.5.6.2 Indonesia Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.5.6.3 Indonesia Dermatology Drug Price (USD/MT)(2012-2017)
  3.5.7 Philippines Dermatology Drug Sales and Revenue (2012-2017)
    3.5.7.1 Philippines Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.5.7.2 Philippines Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.5.7.3 Philippines Dermatology Drug Price (USD/MT)(2012-2017)
  3.5.8 Others Dermatology Drug Sales and Revenue (2012-2017)
    3.5.8.1 Others Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.5.8.2 Others Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.5.8.3 Others Dermatology Drug Price (USD/MT)(2012-2017)
3.6 Middle East & Africa Dermatology Drug Sales and Revenue by Regions (2012-2017)
  3.6.1 Saudi Arabia Dermatology Drug Sales and Revenue (2012-2017)
    3.6.1.1 Saudi Arabia Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.6.1.2 Saudi Arabia Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.6.1.3 Saudi Arabia Dermatology Drug Price (USD/MT)(2012-2017)
  3.6.2 Iran Dermatology Drug Sales and Revenue (2012-2017)
    3.6.2.1 Iran Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.6.2.2 Iran Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.6.2.3 Iran Dermatology Drug Price (USD/MT)(2012-2017)
  3.6.3 UAE Dermatology Drug Sales and Revenue (2012-2017)
    3.6.3.1 UAE Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.6.3.2 UAE Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.6.3.3 UAE Dermatology Drug Price (USD/MT)(2012-2017)
  3.6.4 Turkey Dermatology Drug Sales and Revenue (2012-2017)
    3.6.4.1 Turkey Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.6.4.2 Turkey Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.6.4.3 Turkey Dermatology Drug Price (USD/MT)(2012-2017)
  3.6.5 Israel Dermatology Drug Sales and Revenue (2012-2017)
    3.6.5.1 Israel Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.6.5.2 Israel Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.6.5.3 Israel Dermatology Drug Price (USD/MT)(2012-2017)
  3.6.6 Egypt Dermatology Drug Sales and Revenue (2012-2017)
    3.6.6.1 Egypt Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.6.6.2 Egypt Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.6.6.3 Egypt Dermatology Drug Price (USD/MT)(2012-2017)
  3.6.7 South Africa Dermatology Drug Sales and Revenue (2012-2017)
    3.6.7.1 South Africa Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.6.7.2 South Africa Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.6.7.3 South Africa Dermatology Drug Price (USD/MT)(2012-2017)
  3.6.8 Others Dermatology Drug Sales and Revenue (2012-2017)
    3.6.8.1 Others Dermatology Drug Sales (K MT) and Market Share (2012-2017)
    3.6.8.2 Others Dermatology Drug Revenue (Million USD) and Market Share (2012-2017)
    3.6.8.3 Others Dermatology Drug Price (USD/MT)(2012-2017)

4 GLOBAL AND JAPAN DERMATOLOGY DRUG PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

4.1 AbbVie (U.S.)
  4.1.1 Company Basic Information, Manufacturing Base and Competitors
  4.1.2 Dermatology Drug Product Category, Application and Specification
    4.1.2.1 Product A
    4.1.2.2 Product B
  4.1.3 AbbVie (U.S.) Dermatology Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  4.1.4 Main Business/Business Overview
4.2 Johnson & Johnson (U.S.)
  4.2.1 Company Basic Information, Manufacturing Base and Competitors
  4.2.2 Dermatology Drug Product Category, Application and Specification
    4.2.2.1 Product A
    4.2.2.2 Product B
  4.2.3 Johnson & Johnson (U.S.) Dermatology Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  4.2.4 Main Business/Business Overview
4.3 Bayer (Germany)
  4.3.1 Company Basic Information, Manufacturing Base and Competitors
  4.3.2 Dermatology Drug Product Category, Application and Specification
    4.3.2.1 Product A
    4.3.2.2 Product B
  4.3.3 Bayer (Germany) Dermatology Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  4.3.4 Main Business/Business Overview
4.4 Galderma (Switzerland)
  4.4.1 Company Basic Information, Manufacturing Base and Competitors
  4.4.2 Dermatology Drug Product Category, Application and Specification
    4.4.2.1 Product A
    4.4.2.2 Product B
  4.4.3 Galderma (Switzerland) Dermatology Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  4.4.4 Main Business/Business Overview
4.5 Bristol-Myers Squibb (U.S.)
  4.5.1 Company Basic Information, Manufacturing Base and Competitors
  4.5.2 Dermatology Drug Product Category, Application and Specification
    4.5.2.1 Product A
    4.5.2.2 Product B
  4.5.3 Bristol-Myers Squibb (U.S.) Dermatology Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  4.5.4 Main Business/Business Overview
4.6 Novartis (China)
  4.6.1 Company Basic Information, Manufacturing Base and Competitors
  4.6.2 Dermatology Drug Product Category, Application and Specification
    4.6.2.1 Product A
    4.6.2.2 Product B
  4.6.3 Novartis (China) Dermatology Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  4.6.4 Main Business/Business Overview
4.7 Pfizer (U.S.)
  4.7.1 Company Basic Information, Manufacturing Base and Competitors
  4.7.2 Dermatology Drug Product Category, Application and Specification
    4.7.2.1 Product A
    4.7.2.2 Product B
  4.7.3 Pfizer (U.S.) Dermatology Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  4.7.4 Main Business/Business Overview
4.8 Merz Pharma (Germany)
  4.8.1 Company Basic Information, Manufacturing Base and Competitors
  4.8.2 Dermatology Drug Product Category, Application and Specification
    4.8.2.1 Product A
    4.8.2.2 Product B
  4.8.3 Merz Pharma (Germany) Dermatology Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  4.8.4 Main Business/Business Overview
4.9 Valeant (Canada)
  4.9.1 Company Basic Information, Manufacturing Base and Competitors
  4.9.2 Dermatology Drug Product Category, Application and Specification
    4.9.2.1 Product A
    4.9.2.2 Product B
  4.9.3 Valeant (Canada) Dermatology Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  4.9.4 Main Business/Business Overview
4.10 LEO Pharma (Denmark)
  4.10.1 Company Basic Information, Manufacturing Base and Competitors
  4.10.2 Dermatology Drug Product Category, Application and Specification
    4.10.2.1 Product A
    4.10.2.2 Product B
  4.10.3 LEO Pharma (Denmark) Dermatology Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
  4.10.4 Main Business/Business Overview
4.11 GlaxoSmithKline (UK)

5 DERMATOLOGY DRUG MANUFACTURING COST ANALYSIS

5.1 Dermatology Drug Key Raw Materials Analysis
  5.1.1 Key Raw Materials
  5.1.2 Price Trend of Key Raw Materials
  5.1.3 Key Suppliers of Raw Materials
  5.1.4 Market Concentration Rate of Raw Materials
5.2 Proportion of Manufacturing Cost Structure
  5.2.1 Raw Materials
  5.2.2 Labor Cost
  5.2.3 Manufacturing Expenses
5.3 Manufacturing Process Analysis of Dermatology Drug

6 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

6.1 Dermatology Drug Industrial Chain Analysis
6.2 Upstream Raw Materials Sourcing
6.3 Raw Materials Sources of Dermatology Drug Major Players/Manufacturers in 2016
6.4 Downstream Buyers

7 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

7.1 Marketing Channel
  7.1.1 Direct Marketing
  7.1.2 Indirect Marketing
  7.1.3 Marketing Channel Development Trend
7.2 Market Positioning
  7.2.1 Pricing Strategy
  7.2.2 Brand Strategy
  7.2.3 Target Client
7.3 Distributors/Traders List

8 MARKET EFFECT FACTORS ANALYSIS

8.1 Technology Progress/Risk
  8.1.1 Substitutes Threat
  8.1.2 Technology Progress in Related Industry
8.2 Consumer Needs/Customer Preference Change
8.3 Economic/Political Environmental Change

9 GLOBAL AND JAPAN DERMATOLOGY DRUG MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

9.1 Global and Japan Dermatology Drug Sales (K MT), Revenue (Million USD) Forecast (2017-2022)
9.2 Global and Japan Dermatology Drug Sales (K MT) Forecast by Type (2017-2022)
  9.2.1 by Route of Administration
  9.2.2 by Form
9.3 Global and Japan Dermatology Drug Sales (K MT) Forecast by Application (2017-2022)
9.4 Global and Japan Dermatology Drug Sales (K MT) Forecast by Regions (2017-2022)

10 RESEARCH FINDINGS AND CONCLUSION

11 METHODOLOGY AND DATA SOURCE

11.1 Methodology/Research Approach
  11.1.1 Research Programs/Design
  11.1.2 Market Size Estimation
  11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
  11.2.1 Secondary Sources
  11.2.2 Primary Sources
11.3 Disclaimer
11.4 Author List

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Dermatology Drug
Table Japan Dermatology Drug Sales (Million Units) Comparison by Applications (2012-2017)
Figure Japan Sales Market Share (%) of Dermatology Drug by Applications in 2016
Table Global Dermatology Drug Sales (Million Units) Comparison by Applications (2012-2017)
Figure Global Sales Market Share (%) of Dermatology Drug by Applications in 2016
Figure Psoriasis Examples
Table Key Downstream Customer in Psoriasis
Figure Skin Infections Examples
Table Key Downstream Customer in Skin Infections
Figure Acne Examples
Table Key Downstream Customer in Acne
Figure Dermatitis Examples
Table Key Downstream Customer in Dermatitis
Figure Other Examples
Table Key Downstream Customer in Other
Figure External Use Product Picture
Figure Oral Product Picture
Figure Injection Product Picture
Figure Ointment Product Picture
Figure Liquid Product Picture
Figure Powder Product Picture
Figure Spray Product Picture
Table AbbVie (U.S.) Basic Information List
Table AbbVie (U.S.) Dermatology Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Table AbbVie (U.S.) Dermatology Drug Sales Growth Rate (%)(2012-2017)
Table AbbVie (U.S.) Dermatology Drug Sales Market Share (%) in Japan (2012-2017)
Figure AbbVie (U.S.) Dermatology Drug Revenue Market Share (%) in Japan (2012-2017)
Table Johnson & Johnson (U.S.) Basic Information List
Table Johnson & Johnson (U.S.) Dermatology Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Table Johnson & Johnson (U.S.) Dermatology Drug Sales Growth Rate (%)(2012-2017)
Table Johnson & Johnson (U.S.) Dermatology Drug Sales Market Share (%) in Japan (2012-2017)
Figure Johnson & Johnson (U.S.) Dermatology Drug Revenue Market Share (%) in Japan (2012-2017)
Table Bayer (Germany) Basic Information List
Table Bayer (Germany) Dermatology Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Table Bayer (Germany) Dermatology Drug Sales Growth Rate (%)(2012-2017)
Table Bayer (Germany) Dermatology Drug Sales Market Share (%) in Japan (2012-2017)
Figure Bayer (Germany) Dermatology Drug Revenue Market Share (%) in Japan (2012-2017)
Table Galderma (Switzerland) Basic Information List
Table Galderma (Switzerland) Dermatology Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Table Galderma (Switzerland) Dermatology Drug Sales Growth Rate (%)(2012-2017)
Table Galderma (Switzerland) Dermatology Drug Sales Market Share (%) in Japan (2012-2017)
Figure Galderma (Switzerland) Dermatology Drug Revenue Market Share (%) in Japan (2012-2017)
Table Bristol-Myers Squibb (U.S.) Basic Information List
Table Bristol-Myers Squibb (U.S.) Dermatology Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Table Bristol-Myers Squibb (U.S.) Dermatology Drug Sales Growth Rate (%)(2012-2017)
Table Bristol-Myers Squibb (U.S.) Dermatology Drug Sales Market Share (%) in Japan (2012-2017)
Figure Bristol-Myers Squibb (U.S.) Dermatology Drug Revenue Market Share (%) in Japan (2012-2017)
Table Novartis (China) Basic Information List
Table Novartis (China) Dermatology Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Table Novartis (China) Dermatology Drug Sales Growth Rate (%)(2012-2017)
Table Novartis (China) Dermatology Drug Sales Market Share (%) in Japan (2012-2017)
Figure Novartis (China) Dermatology Drug Revenue Market Share (%) in Japan (2012-2017)
Table Pfizer (U.S.) Basic Information List
Table Pfizer (U.S.) Dermatology Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Table Pfizer (U.S.) Dermatology Drug Sales Growth Rate (%)(2012-2017)
Table Pfizer (U.S.) Dermatology Drug Sales Market Share (%) in Japan (2012-2017)
Figure Pfizer (U.S.) Dermatology Drug Revenue Market Share (%) in Japan (2012-2017)
Table Merz Pharma (Germany) Basic Information List
Table Merz Pharma (Germany) Dermatology Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Table Merz Pharma (Germany) Dermatology Drug Sales Growth Rate (%)(2012-2017)
Table Merz Pharma (Germany) Dermatology Drug Sales Market Share (%) in Japan (2012-2017)
Figure Merz Pharma (Germany) Dermatology Drug Revenue Market Share (%) in Japan (2012-2017)
Table Valeant (Canada) Basic Information List
Table Valeant (Canada) Dermatology Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Table Valeant (Canada) Dermatology Drug Sales Growth Rate (%)(2012-2017)
Table Valeant (Canada) Dermatology Drug Sales Market Share (%) in Japan (2012-2017)
Figure Valeant (Canada) Dermatology Drug Revenue Market Share (%) in Japan (2012-2017)
Table LEO Pharma (Denmark) Basic Information List
Table LEO Pharma (Denmark) Dermatology Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
Table LEO Pharma (Denmark) Dermatology Drug Sales Growth Rate (%)(2012-2017)
Table LEO Pharma (Denmark) Dermatology Drug Sales Market Share (%) in Japan (2012-2017)
Figure LEO Pharma (Denmark) Dermatology Drug Revenue Market Share (%) in Japan (2012-2017)
Table GlaxoSmithKline (UK) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dermatology Drug
Figure Manufacturing Process Analysis of Dermatology Drug
Figure Dermatology Drug Industrial Chain Analysis
Table Raw Materials Sources of Dermatology Drug Major Players/Manufacturers in 2016
Table Major Buyers of Dermatology Drug
Table Distributors/Traders List
Figure Japan Dermatology Drug Sales (K MT) and Growth Rate (%) Forecast (2017-2022)
Figure Japan Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Dermatology Drug Price (USD/MT) Trend Forecast (2017-2022)
Figure Global Dermatology Drug Sales (K MT) and Growth Rate (%) Forecast (2017-2022)
Figure Global Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Dermatology Drug Price (USD/MT) Trend Forecast (2017-2022)
Table Japan Dermatology Drug Sales (K MT) Forecast by Type (2017-2022)
Table Global Dermatology Drug Sales (K MT) Forecast by Type (2017-2022)
Figure Japan Dermatology Drug Sales (K MT) Forecast by Type (2017-2022)
Figure Global Dermatology Drug Sales (K MT) Forecast by Type (2017-2022)
Figure Japan Dermatology Drug Sales Volume Market Share Forecast by Type in 2017
Figure Global Dermatology Drug Sales Volume Market Share Forecast by Type in 2017
Table Japan Dermatology Drug Sales (K MT) Forecast by Application (2017-2022)
Figure Japan Dermatology Drug Sales Volume Market Share Forecast by Application (2017-2022)
Figure Japan Dermatology Drug Sales Volume Market Share Forecast by Application in 2017
Table Global Dermatology Drug Sales (K MT) Forecast by Application (2017-2022)
Figure Global Dermatology Drug Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Dermatology Drug Sales Volume Market Share Forecast by Application in 2017
Table Japan Dermatology Drug Sales (K MT) Forecast by Regions (2017-2022)
Table Japan Dermatology Drug Sales Volume Share Forecast by Regions (2017-2022)
Figure Japan Dermatology Drug Sales Volume Share Forecast by Regions (2017-2022)
Table Global Dermatology Drug Sales (K MT) Forecast by Regions (2017-2022)
Table Global Dermatology Drug Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Dermatology Drug Sales Volume Share Forecast by Regions (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources